195 related articles for article (PubMed ID: 3802700)
1. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
[TBL] [Abstract][Full Text] [Related]
2. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
Bogentoft C; Alpsten M; Ekenved G
J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
[TBL] [Abstract][Full Text] [Related]
3. Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition.
Mojaverian P; Ferguson RK; Vlasses PH; Rocci ML; Oren A; Fix JA; Caldwell LJ; Gardner C
Gastroenterology; 1985 Aug; 89(2):392-7. PubMed ID: 3891497
[TBL] [Abstract][Full Text] [Related]
4. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
Alpsten M; Bogentoft C; Ekenved G; Sölvell L
Eur J Clin Pharmacol; 1982; 22(1):57-61. PubMed ID: 7094976
[TBL] [Abstract][Full Text] [Related]
5. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
Lui CY; Oberle R; Fleisher D; Amidon GL
J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
[TBL] [Abstract][Full Text] [Related]
6. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
Montgomery PR; Sitar DS
Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
[TBL] [Abstract][Full Text] [Related]
7. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
Bogentoft C; Carlsson I; Ekenved G; Magnusson A
Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
[TBL] [Abstract][Full Text] [Related]
8. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
[TBL] [Abstract][Full Text] [Related]
9. Comparative aspirin absorption kinetics after administration of sodium- and potassium-containing buffered solutions.
Mason WD
J Pharm Sci; 1984 Jul; 73(7):998-9. PubMed ID: 6470971
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.
Mason WD; Winer N
J Pharm Sci; 1981 Mar; 70(3):262-5. PubMed ID: 7264888
[TBL] [Abstract][Full Text] [Related]
11. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an enteric coated aspirin preparation.
Day RO; Paull PD; Champion GD; Graham GG
Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.
Cerletti C; Marchi S; Lauri D; Domanin M; Lorenzi G; Urso R; Dejana E; Latini R; de Gaetano G
Clin Pharmacol Ther; 1987 Aug; 42(2):175-80. PubMed ID: 3301151
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady-state levels of salicylic acid and its metabolites in plasma and urine.
Edgar B; Bogentoft C; Lagerström PO
Biopharm Drug Dispos; 1984; 5(3):251-60. PubMed ID: 6541512
[TBL] [Abstract][Full Text] [Related]
16. Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions.
Mazer N; Abisch E; Gfeller JC; Laplanche R; Bauerfeind P; Cucala M; Lukachich M; Blum A
J Pharm Sci; 1988 Aug; 77(8):647-57. PubMed ID: 2974884
[TBL] [Abstract][Full Text] [Related]
17. Food-induced gastric retention and absorption of sustained-release procainamide.
Rocci ML; Mojaverian P; Davis RJ; Ferguson RK; Vlasses PH
Clin Pharmacol Ther; 1987 Jul; 42(1):45-9. PubMed ID: 2439252
[TBL] [Abstract][Full Text] [Related]
18. Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector.
Ewe K; Press AG; Bollen S; Schuhn I
Dig Dis Sci; 1991 Feb; 36(2):146-52. PubMed ID: 1988257
[TBL] [Abstract][Full Text] [Related]
19. Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine.
Buskin JN; Upton RA; Williams RL
Clin Chem; 1982 May; 28(5):1200-3. PubMed ID: 7074905
[TBL] [Abstract][Full Text] [Related]
20. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
Portek I; Graham G; Fleming A
Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
